Asymmetric synthesis of the vasopeptidase inhibitor BMS-189921

ORGN 212

David R. Kronenthal, Process Research and Development, Process Research and Development, Bristol-Myers Squibb Pharmaceutical Research Institute, 1 Squibb Drive, New Brunswick, NJ 08903
The development of the synthesis of the vasopeptidase inhibitor BMS-189921 will be presented.

 

Role of Organic Synthesis in Early Clinical Drug Development
8:30 AM-11:55 AM, Monday, September 8, 2003 Sheraton New York -- Imperial Ballroom A, Oral

Division of Organic Chemistry
The 226th ACS National Meeting, New York, NY, September 7-11, 2003